CBD / Hemp

©Getty Images - Nastco

Bipartisan Senate CBD bill introduced

By Hank Schultz

A US Senate bill to specifically allow the use of CBD and other hemp derivatives in dietary supplements and foods has been introduced with bipartisan sponsorship. The bill also enjoys broad support within the industry.

NutraCast: Stuart Titus, PhD, on CBN for Sleep

NutraCast: Stuart Titus, PhD, on CBN for Sleep

By Danielle Masterson

Many of us know that valerian root, ashwagandha, chamomile and melatonin are helpful in delivering a good night’s rest. But how about CBN? Stuart Titus, PhD, CEO and president at Medical Marijuana, said that cannabinol hasn't really been available...

Getty Images / Vladyslava Yakovenko

April new product roundup

By Danielle Masterson

Spray delivery systems, CBN, and the sleep category lead this month's wellness wave.

AHPA's McGuffin on DSHEA 2.0, CBD's path forward, and more

AHPA's McGuffin on DSHEA 2.0, CBD's path forward, and more

By Stephen Daniells

While AHPA supports H.R.841, the association wishes FDA “would do its job and establish a legal pathway [for hemp and CBD], but they haven’t,” said Michael McGuffin. “Something needs to happen.”

CRN’s Mister on the best solution for CBD, DSHEA 2.0, and more

CRN’s Mister on the best solution for CBD, DSHEA 2.0, and more

By Stephen Daniells

The Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act represents ‘the best way’ to deal with the hemp-CBD issue for dietary supplements, says CRN’s Steve Mister, and once that’s clarified then the FDA and industry can address...

Rugby warriors tackle cannabinoid concerns with CBD startup

Editor's Spotlight: Startup Focus

Rugby warriors tackle cannabinoid concerns with CBD startup

By Nikki Hancocks

Two professional rugby players have created a startup selling third-party tested CBD supplements that give elite athletes and everyday consumers peace of mind over cannabinoid content

NPA’s Fabricant on CBD, NDI-related import alerts, and banned stimulants

NPA’s Fabricant on CBD, NDI-related import alerts, and banned stimulants

By Stephen Daniells

Efforts to move the needle on hemp-CBD at the Federal level are slow, and upcoming exits of key personnel at FDA are unlikely to affect progress much, says NPA’s Dr Daniel Fabricant. “In some ways I think FDA likes the status quo,” he tells NutraIngredients-USA.

NutraWomen Wednesday: Amanda Jones, co-founder of Kikoko

NutraWomen Wednesday: Amanda Jones, co-founder of Kikoko

By Danielle Masterson

Before her foray into the botanical wellness industry, Amanda Jones spent two decades traveling the world as a journalist for Vogue Magazine. While it may sound like a luxurious position, Jones' work also put her up close and personal with women...

Colorado Gov. Jared Polis spoke at the NoCo Hemp Expo in Denver on Friday.  NutraIngredients-USA photo.

Colorado unveils plan to bolster state support of hemp industry

By Hank Schultz

The state of Colorado aims to remain a leader in the hemp industry, Gov. Jared Polis said at an industry event last week. He announced the release of a detailed state plan for the industry at the meeting, which includes scientific support, data sharing,...

getty | tinnakorn jorruang

CBD novel foods deadline delayed amid last minute applications

By Nikki Hancocks

The FSA (Food Standards Agency) has backtracked on its initial expectation for companies to make their novel foods applications at least five weeks in advance of the deadline and confirmed that it will accept applications up until March 31st, after receiving...

Pic:CanopyGrowth

Canopy Growth launches CBD beverages in the US

By Rachel Arthur

Canopy Growth Corporation is entering the ‘high-potential US CBD beverage category’ with its premium ready-to-drink CBD-infused sparkling water Quatreau.

© Andrey Maximenko / Getty Images

Pet supplement sales surged 21% in 2020: Report

By Stephen Daniells

Mirroring the human dietary supplement category, sales of pet supplements also skyrocketed in 2020, with Packaged Facts reporting that growth rates quadrupling in 2020 from 2019.

Getty Images / 24K-Production

FDA yanks pending CBD enforcement proposal

By Danielle Masterson

The White House Office of Management and Budget pulled six FDA guidances and rules from its review, including the proposal "Cannabidiol Enforcement Policy; Draft Guidance for Industry" — handing the CBD industry yet another setback.

Follow us

Products

View more

Webinars